1. Increasing prevalence of thyroid disorders worldwide, leading to a higher demand for thyroid function tests.
2. Advancements in technology leading to the development of more accurate and efficient thyroid function testing methods.
3. Growing awareness about the importance of early detection and management of thyroid disorders.
4. Rising healthcare expenditure and an increased focus on preventive healthcare measures globally.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Type, End User |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Abbott, BioMérieux SA, F. Hoffmann-La, Roche, Thermo Fisher Scientific, Danaher, Merck, Diasorin, Diagnostic Automation/Cortez Diagnostics, Qualigen, and Kronus. |
1. High cost associated with thyroid function testing, especially in developing countries, limiting access to testing for a significant portion of the population.
2. Stringent regulatory requirements and approval processes for new thyroid function testing products, hindering market growth.
3. Limited availability of skilled healthcare professionals and infrastructure in certain regions, impacting the adoption of thyroid function tests.